AI assistant
Marksans Pharma Ltd. — Regulatory Filings 2021
Nov 26, 2021
62142_rns_2021-11-26_e00bb05a-189b-493b-ab52-659164a4de60.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
·t· Marksans Pharma Ltd.
BSE Limited
Corporate Relation Department PhirozeJeejeeboi Towers, Dalal Street, Mumbai - 400001. Scrip Code: 524404
National Stock ExchangeofIndia Limited Listing Department Exchange Plaza, C-l, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai -400051. Syrnbol:MilRJ(S)~S
Sub: Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish details of issue of duplicate of share certificate as given hereinbelow on ~ ovember 26, 2021 :
==> picture [456 x 105] intentionally omitted <==
----- Start of picture text ----- Sr. Folio Name of the Old Share New Share Share No. ofNo. No. Shareholders Certificate Certificate Distinctive SharesNo. No Nos. From-To1.)\001070 )\ditya Saran 49 1094 1080001- 10001081000----- End of picture text -----
Yours faithfully, For Marksans Pharma Limited
jJ())M5~C -::-:-
.-::-:-
,.. Harshavardhan Panigrahi Compan1'" Secretary
Marksans Pharma Ltd.
~ 1~~FI.oor,"GRAND.EUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara n en (W), Mumbal - 400 053 • Tel.: +91 224001 2000 • E-mail: [email protected]~ www.marksanspharma.com